Transcriptomics

Dataset Information

0

Antitumor efficacy of sequence specific DNA-targeted gamma PNA based cMyc inhibitor


ABSTRACT: Targeting oncogenes at the genomic DNA level can open new avenues for precision medicine. Significant efforts are ongoing to target oncogenes using diverse RNA-targeted and protein-targeted platforms, but no progress has been made to target genomic DNA for cancer therapy. Here, we introduce a gamma peptide nucleic acid (PNA)-based genomic DNA-targeted platform to silence oncogenes in vivo. gPNAs can efficiently invade the mixed sequences of genomic DNA with high affinity and specificity. As a proof-of-concept, we established that gPNA could inhibit c-Myc transcription in multiple cell lines. In vivo efficacy and safety of the DNA-targeted approach were demonstrated in three pre-clinical models. We also established that anti-transcription gPNA in combination with histone deacetylase inhibitors (HDACi) and chemotherapeutic drugs results in high and robust antitumor activity in cell-line and patient-derived xenografts. Overall, this strategy offers a unique therapeutic platform to target genomic DNA to inhibit oncogenes for cancer therapy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE246439 | GEO | 2023/11/16

REPOSITORIES: GEO

Similar Datasets

2009-05-14 | GSE11269 | GEO
2022-04-28 | GSE191313 | GEO
2021-03-01 | GSE152740 | GEO
2021-03-04 | GSE168166 | GEO
2020-08-28 | GSE156960 | GEO
2020-08-28 | GSE156895 | GEO
2017-11-01 | GSE103056 | GEO
2011-12-31 | E-GEOD-7959 | biostudies-arrayexpress
| PRJNA471375 | ENA
2011-12-31 | GSE7959 | GEO